UPDATE 1-Kite to launch mid-stage leukemia trial in fourth quarter 2017
June 05, 2017 at 17:40 PM EDT
CHICAGO, June 5 (Reuters) - Kite Pharma Inc and Juno Therapeutics Inc on Monday presented new data for their experimental T-cell therapies, but investors were not overly impressed and shares of Juno fell nearly 11 percent.
